{
  "meta": {
    "title": "24_Transplant_Immunity",
    "url": "https://brainandscalpel.vercel.app/24-transplant-immunity-e9c05453.html",
    "scrapedAt": "2025-11-30T18:15:45.088Z"
  },
  "questions": [
    {
      "text": "A 20-year-old girl was diagnosed with acute lymphoblastic leukaemia (ALL). Her medical team has determined that a bone marrow transplant is necessary to achieve remission and prevent disease recurrence. She has an identical twin sister, who is an eligible donor. What type of grafting was done on this patient?",
      "choices": [
        {
          "id": 0,
          "text": "Allograft"
        },
        {
          "id": 1,
          "text": "Autograft"
        },
        {
          "id": 2,
          "text": "Isograft"
        },
        {
          "id": 3,
          "text": "Xenograft"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct answer: C) Isograft</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<p>A <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> from an identical twin donor is called an <strong>isograft.</strong></p>\n\n<p>An <span class=\"customMeta\" data-dictid=\"02ba5261981692777190ca895acc87\">isograft</span> is an organ or tissue taken from a donor and transplanted to a recipient with the <strong>same genetic constitution</strong> as the donor.</p>\n\n<p> </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:716px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #0d0d0d; border-left:1px solid #0d0d0d; border-right:1px solid #0d0d0d; border-top:1px solid #0d0d0d; vertical-align:bottom\">\n\t\t\t<p><strong>Type of Graft</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #0d0d0d; border-left:1px solid #0d0d0d; border-right:1px solid #0d0d0d; border-top:1px solid #0d0d0d; vertical-align:bottom\">\n\t\t\t<p><strong>Description</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #0d0d0d; border-left:1px solid #0d0d0d; border-right:1px solid #0d0d0d; border-top:1px solid #0d0d0d; vertical-align:middle\">\n\t\t\t<p><strong>Autograft</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #0d0d0d; border-left:1px solid #0d0d0d; border-right:1px solid #0d0d0d; border-top:1px solid #0d0d0d; vertical-align:middle\">\n\t\t\t<p>An organ or tissue is taken from an individual and grafted on him/ herself</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #0d0d0d; border-left:1px solid #0d0d0d; border-right:1px solid #0d0d0d; border-top:1px solid #0d0d0d; vertical-align:middle\">\n\t\t\t<p><strong>Isograft</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #0d0d0d; border-left:1px solid #0d0d0d; border-right:1px solid #0d0d0d; border-top:1px solid #0d0d0d; vertical-align:middle\">\n\t\t\t<p>Grafts between genetically identical individuals, such as identical twins</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #0d0d0d; border-left:1px solid #0d0d0d; border-right:1px solid #0d0d0d; border-top:1px solid #0d0d0d; vertical-align:middle\">\n\t\t\t<p><strong>Allograft</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #0d0d0d; border-left:1px solid #0d0d0d; border-right:1px solid #0d0d0d; border-top:1px solid #0d0d0d; vertical-align:middle\">\n\t\t\t<p>Graft between two genetically non-identical members of the same species (e.g. organ transplants between two non-identical and <span class=\"customMeta\" data-dictid=\"8baf7b24c316927771847e2b2ae466\">compatible</span> individuals.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #0d0d0d; border-left:1px solid #0d0d0d; border-right:1px solid #0d0d0d; border-top:1px solid #0d0d0d; vertical-align:middle\">\n\t\t\t<p><strong>Xenograft</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #0d0d0d; border-left:1px solid #0d0d0d; border-right:1px solid #0d0d0d; border-top:1px solid #0d0d0d; vertical-align:middle\">\n\t\t\t<p>Graft from one species to another (e.g., pig skin is a temporary <span class=\"customMeta\" data-dictid=\"02f0c206e716927771999e45b2d63b\">substitute</span> for burn treatment).</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #0d0d0d; border-left:1px solid #0d0d0d; border-right:1px solid #0d0d0d; border-top:1px solid #0d0d0d; vertical-align:middle\">\n\t\t\t<p><strong>Synthetic Graft</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #0d0d0d; border-left:1px solid #0d0d0d; border-right:1px solid #0d0d0d; border-top:1px solid #0d0d0d; vertical-align:middle\">\n\t\t\t<p>Artificial materials or bioengineered constructs replace or support damaged tissue (e.g., artificial skin substitutes, <span class=\"customMeta\" data-dictid=\"c293dda462169277718335b755e1a9\">bone graft</span> substitutes).</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/ndaBsamEv7TCmwIrGDNN1750241713.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/vxUoMUX9SkXxOj5BM7xY1750241851.mp3"
    },
    {
      "text": "What is the minimum HLA matching that should be achieved to proceed with the transplant in the pediatric population?",
      "choices": [
        {
          "id": 0,
          "text": "4/6"
        },
        {
          "id": 1,
          "text": "6/6"
        },
        {
          "id": 2,
          "text": "6/8"
        },
        {
          "id": 3,
          "text": "8/10"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct answer:</strong> <strong>A) 4/6</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation: </strong></p>\n\n<p>4/6 <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> matches, 3 alleles from each parent ( hence 6), including HLA-A, HLA-B, and HLA-DR, are required in a <span class=\"customMeta\" data-dictid=\"318e52e4751692777195acbcdf4551\">pediatric</span> group for <span class=\"customMeta\" data-dictid=\"812d0ddedb1692777181aaf62743b1\">allogeneic</span> transplants. Two important aspects to be considered before transplant are <span class=\"customMeta\" data-dictid=\"4bc84ee03c1692777180863d427fb5\">ABO blood group</span> <span class=\"customMeta\" data-dictid=\"75e8739695169277719138884fec36\">matching</span> and <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> <span class=\"customMeta\" data-dictid=\"75e8739695169277719138884fec36\">matching</span> between donors and recipients.</p>\n\n<ul>\n\t<li>HLA <span class=\"customMeta\" data-dictid=\"75e8739695169277719138884fec36\">matching</span> is not done for the <span class=\"customMeta\" data-dictid=\"4cc4d657841692777185555e1b982d\">cornea</span> as it is avascular. It is generally less critical for heart, lung, and liver transplants than <span class=\"customMeta\" data-dictid=\"d2e0ab499c169277718886ab5a46bf\">hematopoietic</span> stem cell transplants.</li>\n\t<li>HLA-A, B, C, DQ, and DR are the main genes targeted to match before transplantation, with <strong>HLA-DR being the most important one.</strong></li>\n\t<li>For adult <span class=\"customMeta\" data-dictid=\"d2e0ab499c169277718886ab5a46bf\">hematopoietic</span> stem cell transplants, an ideal match should have a minimum of 8/10 alleles to be considered for transplant.</li>\n\t<li>In practice, a match of a minimum of 6/8 alleles <span class=\"customMeta\" data-dictid=\"e4865847fa169277720044d7b530b0\">targeting</span> HLA-A, B, C, and DR is often used for adult transplants.</li>\n\t<li>In children, a match of at least 4/6 genes involving <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> - A, B, and DR is required.</li>\n\t<li>Identical twins will always have complete 6/6 <span class=\"customMeta\" data-dictid=\"75e8739695169277719138884fec36\">matching</span> genes.</li>\n</ul>\n\n<p><br />\n </p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:NaN\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>If these <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> Antigens and Alleles Match</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Then, the donor is considered to be this type of match:</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>A, B and DRB1</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>6/6</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>A, B, C, and DRB1</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>8/8</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>A, B, C, DRB1 and DQB1</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>10/10</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>A, B, C, DRB1, DQB1 and DPB1</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>12/12</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/YCuMEHxMbEbJpNIeNyMx1750241907.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/hXIYQKz4BVrFyy9S6PNa1750241960.mp3"
    },
    {
      "text": "A 35-year-old woman with end-stage renal disease recently received a compatible donor organ from her brother. The kidney transplant surgery proceeds as planned, but within minutes of reperfusion, the kidney becomes mottled, cyanotic and anuric. What is the cause for this presentation?",
      "choices": [
        {
          "id": 0,
          "text": "Preformed antibodies in the donor"
        },
        {
          "id": 1,
          "text": "Preformed antibodies in the recipient"
        },
        {
          "id": 2,
          "text": "Cytotoxic T-lymphocyte-mediated injury"
        },
        {
          "id": 3,
          "text": "CD4+ cells mediated inflammation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct answer: B) Preformed antibodies in the recipient</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation: </strong> The given clinical scenario suggests <span class=\"customMeta\" data-dictid=\"c7c23b05e116927771899b5232b3d7\">hyperacute</span> <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> due to preformed antibodies in the recipient. Antibodies specific for antigens on <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> endothelial cells immediately react with the graft, leading to endothelial injury, rapid <span class=\"customMeta\" data-dictid=\"3e745919391692777200fae21b7251\">thrombosis</span> and <span class=\"customMeta\" data-dictid=\"0f670d10711692777190af4b12fac9\">ischemia</span> of the transplanted organ.</p>\n\n<ul>\n\t<li>Hyperacute <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> occurs within minutes to hours after or even during transplantation and is characterised by the following:</li>\n</ul>\n\n<ul>\n\t<li><strong>Mechanism:</strong> It is mediated by preformed antibodies in the recipient's blood that react against donor antigens on the graft's <span class=\"customMeta\" data-dictid=\"526ede3fee169277720184378acc5e\">vascular</span> endothelium. (Type 2 <span class=\"customMeta\" data-dictid=\"2c7e1ce33316927771892ce1da8276\">hypersensitivity</span> reaction)</li>\n\t<li><strong>Antibodies involved:</strong> These are usually anti-HLA antibodies or <span class=\"customMeta\" data-dictid=\"4bc84ee03c1692777180863d427fb5\">ABO blood group</span> antibodies that the recipient has developed due to previous exposures such as pregnancies, blood transfusions, or previous transplants.</li>\n\t<li><strong>Pathophysiology:</strong> When these antibodies bind to the graft's endothelium, they <span class=\"customMeta\" data-dictid=\"dddc752e1716927771807f985bb8bb\">activate</span> the <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> system, leading to rapid <span class=\"customMeta\" data-dictid=\"3e745919391692777200fae21b7251\">thrombosis</span> and <span class=\"customMeta\" data-dictid=\"896c5469811692777194e64e7ccef7\">occlusion</span> of the <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> vessels.</li>\n\t<li><strong>Histology:</strong> The arterioles of the affected <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">kidney</span> develop <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"43b1f01822169277720222a3b354dd\">fibrinoid</span> necrosis, with <span class=\"customMeta\" data-dictid=\"fc23eb4c0a16927772003dff4101cd\">thrombi</span> narrowing or occluding their lumens.</li>\n\t<li><strong>Option C:(cytotoxic T-lymphocyte-mediated injury) and D (CD4+ cell-mediated inflammation) </strong>are involved in <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"12a6f23332169277718402ca6703e2\">cellular</span> rejection, which occurs days to weeks after transplantation, not within minutes, as described in this scenario.</li>\n\t<li>Hyperacute <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> can be prevented by cross-matching ABO and <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> of donor and recipient before transplantation</li>\n</ul>\n\n<p><strong>Histological findings:</strong></p>\n\n<p><img alt=\"\" data-author=\"\"Miguel González-Molinaa, , Pedro Ruiz-Estebana, Abelardo Caballerob, Dolores Burgosa, Mercedes Cabelloa, Miriam Leonc, Laura Fuentesa, Domingo Hernandeza\"\" data-hash=\"\" data-license=\"CC BY-NC ND 4.0\" data-source=\"https://www.revistanefrologia.com/en-immune-response-histology-humoral-rejection-in-kidney-transplantation-articulo-S0211699516300303\" data-tags=\"\" height=\"4167\" src=\"https://image.prepladder.com/content/j71FtLJyyp1iEg2RcIm21737003122.png\" width=\"4061\" /></p>\n\n<p style=\"text-align:center\"><strong>Hyperacute <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> of a <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">kidney</span> <span class=\"customMeta\" data-dictid=\"44d3120c8f16927771815478ab1d1f\">allograft</span> showing <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> <span class=\"customMeta\" data-dictid=\"18c2380be716927772020c9b2863de\">fibrin</span> <span class=\"customMeta\" data-dictid=\"fc23eb4c0a16927772003dff4101cd\">thrombi</span> and severe ischemic injury in a glomerulus.</strong></p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/content/j71FtLJyyp1iEg2RcIm21737003122.png"
      ],
      "explanation_audio_eng": "https://image.prepladder.com/content/8fARntRiunPMc76NVubR1750242067.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/1CUUBjoqAq9K68cfaHlt1750242183.mp3"
    },
    {
      "text": "A 45-year-old man, two months post-kidney transplant, presents with sudden oliguria, fever, and graft site swelling. Biopsy shows glomerular and peritubular capillary inflammation with complement deposition. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 0,
          "text": "Acute humoral rejection"
        },
        {
          "id": 1,
          "text": "Acute calcineurin inhibitor nephrotoxicity"
        },
        {
          "id": 2,
          "text": "Acute cellular rejection"
        },
        {
          "id": 3,
          "text": "BK virus infection"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct answer: </strong>A) <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">Acute</span> <span class=\"customMeta\" data-dictid=\"1a6d065f851692777189ba5533d1ef\">humoral</span> rejection</p>\n\n<p> </p>\n\n<p><strong>Explanation: </strong></p>\n\n<p>Acute <span class=\"customMeta\" data-dictid=\"1a6d065f851692777189ba5533d1ef\">humoral</span> rejection, also known as <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> antibody-mediated <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> (ABMR), is the most likely diagnosis.</p>\n\n<ul>\n\t<li>The presentation occurs two months post-transplant, which is a typical timeframe for <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"1a6d065f851692777189ba5533d1ef\">humoral</span> rejection. It usually occurs within the first year after <span class=\"customMeta\" data-dictid=\"ee9f07b0a81692777200e416e4e5d7\">transplantation</span> but can happen at any time.</li>\n</ul>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:NaN\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Acute <span class=\"customMeta\" data-dictid=\"1a6d065f851692777189ba5533d1ef\">humoral</span> rejection</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Acute <span class=\"customMeta\" data-dictid=\"12a6f23332169277718402ca6703e2\">cellular</span> rejection</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Acute <span class=\"customMeta\" data-dictid=\"1a6d065f851692777189ba5533d1ef\">humoral</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> mediated by newly synthesized antibodies.</li>\n\t\t\t\t<li>It causes endothelial damage and <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> activation.</li>\n\t\t\t\t<li><strong>Type II or IV hypersensitivity.</strong></li>\n\t\t\t\t<li>No response to increasing doses of <span class=\"customMeta\" data-dictid=\"c3c986cd721692777189b473814b2e\">immunosuppressive</span> drugs.</li>\n\t\t\t\t<li><strong>Treatment:</strong> B cell depleting agents.</li>\n\t\t\t\t<li><strong>Microscopic appearance:</strong>\n\t\t\t\t<ul>\n\t\t\t\t\t<li>Fibrinoid <span class=\"customMeta\" data-dictid=\"5e84a7987c16927771931012aced83\">necrosis</span> in vessels.</li>\n\t\t\t\t\t<li>Deposition of C4d in <span class=\"customMeta\" data-dictid=\"ce12dc160c1692777195473ab2cc21\">peritubular</span> capillaries. (Complement <span class=\"customMeta\" data-dictid=\"903370f259169277718385f6060dd7\">breakdown</span> product).</li>\n\t\t\t\t</ul>\n\t\t\t\t</li>\n\t\t\t\t<li><strong>C4d is the marker for <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"1a6d065f851692777189ba5533d1ef\">humoral</span> rejection.</strong></li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Mediated by CD4+ or CD8+ T cells.</li>\n\t\t\t\t<li><strong>Type IV <span class=\"customMeta\" data-dictid=\"2c7e1ce33316927771892ce1da8276\">hypersensitivity</span> reaction.</strong></li>\n\t\t\t\t<li>Responsive to increasing doses of <span class=\"customMeta\" data-dictid=\"c3c986cd721692777189b473814b2e\">immunosuppressive</span> drugs.</li>\n\t\t\t\t<li><strong>Microscopic appearance:</strong>\n\t\t\t\t<ul>\n\t\t\t\t\t<li>Tubulointerstitial pattern:</li>\n\t\t\t\t\t<li>Tubulitis :</li>\n\t\t\t\t\t<li>Destruction of tubules + <span class=\"customMeta\" data-dictid=\"9d21dd5d3116927771907405b181bc\">inflammatory</span> cells in tubules.</li>\n\t\t\t\t\t<li>mononuclear <span class=\"customMeta\" data-dictid=\"9d21dd5d3116927771907405b181bc\">inflammatory</span> infiltrate.</li>\n\t\t\t\t\t<li>vascular pattern:</li>\n\t\t\t\t\t<li>Endothelitis</li>\n\t\t\t\t</ul>\n\t\t\t\t</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<ul>\n\t<li>CD8+ T cells directly destroy <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> cells, or CD4+ cells <span class=\"customMeta\" data-dictid=\"7b8c92219216927771981950fdd0e8\">secrete</span> cytokines and induce inflammation, which damages the graft. Two types of <span class=\"customMeta\" data-dictid=\"12a6f23332169277718402ca6703e2\">cellular</span> <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> rejection:\n\t<ul>\n\t\t<li>In the <span class=\"customMeta\" data-dictid=\"11a108da951692777201ccf7220331\">tubulointerstitial</span> pattern, there is extensive <span class=\"customMeta\" data-dictid=\"f46ba26d111692777190def3b1d80a\">interstitial</span> <span class=\"customMeta\" data-dictid=\"e747a47db616927771908bff4b8931\">inflammation</span> and tubulitis.</li>\n\t\t<li>In the <span class=\"customMeta\" data-dictid=\"526ede3fee169277720184378acc5e\">vascular</span> pattern, there is <span class=\"customMeta\" data-dictid=\"e747a47db616927771908bff4b8931\">inflammation</span> of vessels and <span class=\"customMeta\" data-dictid=\"5e84a7987c16927771931012aced83\">necrosis</span> of vessel walls.</li>\n\t</ul>\n\t</li>\n\t<li><strong>Clinical presentation:</strong>\n\t<ul>\n\t\t<li>Sudden <span class=\"customMeta\" data-dictid=\"a37e635d211692777194eb7748e0cf\">oliguria</span> indicates a rapid decline in <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> function</li>\n\t\t<li>Fever and <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> site <span class=\"customMeta\" data-dictid=\"e3d212ebd316927771996e0c472d4a\">swelling</span> are consistent with an <span class=\"customMeta\" data-dictid=\"9d21dd5d3116927771907405b181bc\">inflammatory</span> process</li>\n\t\t<li>These symptoms suggest an <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> episode rather than a more gradual process</li>\n\t</ul>\n\t</li>\n\t<li><strong>Biopsy findings: </strong>The <span class=\"customMeta\" data-dictid=\"754ab07a2e1692777183ed178c883d\">biopsy</span> shows inflamed <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">kidney</span> filters and small blood vessels with <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> proteins.\n\t<ul>\n\t\t<li>Inflammation in <span class=\"customMeta\" data-dictid=\"c9bd75ce5f1692777188f7fe800061\">glomeruli</span> and <span class=\"customMeta\" data-dictid=\"ce12dc160c1692777195473ab2cc21\">peritubular</span> capillaries is a hallmark of antibody-mediated injury</li>\n\t\t<li>Complement deposition indicates <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> of the <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> <span class=\"customMeta\" data-dictid=\"6826aa04ef16927771833336e53730\">cascade</span> by antibodies</li>\n\t</ul>\n\t</li>\n\t<li>Acute <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> can be prevented by <span class=\"customMeta\" data-dictid=\"498d3df3a416927771894f595a597a\">Immunosuppression</span> drugs.</li>\n</ul>\n\n<p> </p>\n\n<p>Acute <span class=\"customMeta\" data-dictid=\"746f157681169277718323a004b1d4\">calcineurin</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> nephrotoxicity<strong> (Option B)</strong>: Typically doesn't cause fever or <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> site swelling. <span class=\"customMeta\" data-dictid=\"754ab07a2e1692777183ed178c883d\">Biopsy</span> in this condition shows <span class=\"customMeta\" data-dictid=\"98d387b7bd1692777201278b27be72\">tubular</span> injury and <strong>arteriolar hyalinosis,</strong> rather than the <span class=\"customMeta\" data-dictid=\"1ad1e71a4a1692777188853097f685\">glomerular</span> <span class=\"customMeta\" data-dictid=\"e747a47db616927771908bff4b8931\">inflammation</span> or <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> deposition seen in this case.</p>\n\n<p>Acute <span class=\"customMeta\" data-dictid=\"12a6f23332169277718402ca6703e2\">cellular</span> rejection<strong> (Option C)</strong>: While <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"12a6f23332169277718402ca6703e2\">cellular</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> can cause fever and <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> dysfunction, its <span class=\"customMeta\" data-dictid=\"754ab07a2e1692777183ed178c883d\">biopsy</span> findings differ from this case. It shows <span class=\"customMeta\" data-dictid=\"6df1a47d5f1692777201716786223b\">tubulitis</span> and T-cell infiltration, not <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> deposition. This type of <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> is T-cell mediated, unlike the antibody-mediated process suggested by the <span class=\"customMeta\" data-dictid=\"754ab07a2e1692777183ed178c883d\">biopsy</span> findings here.</p>\n\n<p>BK virus infection<strong> (Option D)</strong>: This usually presents more gradually, 2- 6 months post-transplant, due to immunosuppression, and rarely causes fever or <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> swelling. <span class=\"customMeta\" data-dictid=\"754ab07a2e1692777183ed178c883d\">Biopsy</span> in BK virus infection shows <span class=\"customMeta\" data-dictid=\"5cc2d9fac616927772021889ee6d52\">viral</span> <span class=\"customMeta\" data-dictid=\"e741bdc8c616927771854de14e6833\">cytopathic</span> changes in <span class=\"customMeta\" data-dictid=\"98d387b7bd1692777201278b27be72\">tubular</span> cells (decoy cells), not the <span class=\"customMeta\" data-dictid=\"1ad1e71a4a1692777188853097f685\">glomerular</span> <span class=\"customMeta\" data-dictid=\"e747a47db616927771908bff4b8931\">inflammation</span> described.</p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/W4tL1QESRiJsVQ7nqUtQ1750242289.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/SaLjBc1gJmsqu64iasLa1750242383.mp3"
    },
    {
      "text": "A 45-year-old male patient presents with a widespread rash, severe diarrhoea, and jaundice. He underwent bonemarrow transplantation for acute myeloid leukaemia and received cells from a matched, unrelated donor. Which is the most likely diagnosis?",
      "choices": [
        {
          "id": 0,
          "text": "Acute transplant rejection"
        },
        {
          "id": 1,
          "text": "Chronic transplant rejection"
        },
        {
          "id": 2,
          "text": "Graft-versus-host disease"
        },
        {
          "id": 3,
          "text": "Immune reconstitution inflammatory syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer: C) </strong>Graft-versus-host disease</p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<p>The given clinical presentation and history of <span class=\"customMeta\" data-dictid=\"d2e0ab499c169277718886ab5a46bf\">hematopoietic</span> stem cell (HSC) transplant suggests that the patient most likely has graft-versus-host disease (GVHD)</p>\n\n<p> </p>\n\n<ul>\n\t<li>GVHD occurs when immunologically competent cells of the donor are transplanted into <span class=\"customMeta\" data-dictid=\"a3cc9f976916927771895692a1a8a0\">immunocompromised</span> recipients, and donor cells recognise antigens in the host and attack them.</li>\n\t<li>This is seen in <span class=\"customMeta\" data-dictid=\"31f3475bb416927771894ea8f40643\">HSC</span> transplantation, <span class=\"customMeta\" data-dictid=\"ee9f07b0a81692777200e416e4e5d7\">transplantation</span> of solid organs rich in <span class=\"customMeta\" data-dictid=\"32599f889a169277719169e3483e62\">lymphoid</span> cells (e.g., liver), or <span class=\"customMeta\" data-dictid=\"cbb73554631692777200444a9ea263\">transfusion</span> of unirradiated blood.</li>\n\t<li>Immunocompetent T cells in donor tissue recognise the recipient’s <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> antigens as foreign and react against them.</li>\n\t<li>Acute <span class=\"customMeta\" data-dictid=\"d9a4e6300416927771881233c6aafc\">GVHD</span> occurs within days to weeks after <span class=\"customMeta\" data-dictid=\"812d0ddedb1692777181aaf62743b1\">allogeneic</span> <span class=\"customMeta\" data-dictid=\"31f3475bb416927771894ea8f40643\">HSC</span> transplantation.\n\t<ul>\n\t\t<li>Major affected organs: skin (rash), liver (jaundice), and intestines (diarrhoea).</li>\n\t</ul>\n\t</li>\n</ul>\n\n<ul>\n\t<li>Chronic <span class=\"customMeta\" data-dictid=\"d9a4e6300416927771881233c6aafc\">GVHD</span> can lead to <span class=\"customMeta\" data-dictid=\"21e2d5a70616927772021fcdec0ca9\">fibrosis</span> and long-term complications.</li>\n\t<li>Prevention includes <strong>T-cell depletion</strong> of donor cells before <strong>transfusion or <span class=\"customMeta\" data-dictid=\"5b9831f3aa169277718395d7361df6\">bone marrow</span> transplantation.</strong></li>\n\t<li>In acute/ chronic <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> rejection, the recipient's immune system attacks the graft; while in GVHD, donor T cells attack the recipient's <span class=\"customMeta\" data-dictid=\"b1debe2a7c16927771890479332d98\">HLA</span> antigens.</li>\n\t<li>Acute/ chronic <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> presents as the failure of <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> function, local site <span class=\"customMeta\" data-dictid=\"e747a47db616927771908bff4b8931\">inflammation</span> and fever.</li>\n</ul>\n\n<p><strong>Immune <span class=\"customMeta\" data-dictid=\"13783dcacb1692777197d7062e0d6e\">reconstitution</span> <span class=\"customMeta\" data-dictid=\"9d21dd5d3116927771907405b181bc\">inflammatory</span> syndrome (IRIS) (Option D):</strong></p>\n\n<ul>\n\t<li>Immune <span class=\"customMeta\" data-dictid=\"13783dcacb1692777197d7062e0d6e\">reconstitution</span> <span class=\"customMeta\" data-dictid=\"9d21dd5d3116927771907405b181bc\">inflammatory</span> syndrome (IRIS) is an exaggerated <span class=\"customMeta\" data-dictid=\"dc6add5cf91692777189b30a6bae38\">immune response</span> that occurs in HIV-infected patients after <span class=\"customMeta\" data-dictid=\"4019cd26841692777181fa4c0c5a6a\">antiretroviral</span> therapy (ART).</li>\n\t<li>HIV patients are immunocompromised, so if TB infection occurs in them, there is less <span class=\"customMeta\" data-dictid=\"9d21dd5d3116927771907405b181bc\">inflammatory</span> response in the body against TB.</li>\n\t<li>But if ART therapy is given before ATT, their <span class=\"customMeta\" data-dictid=\"4f9ee631c21692777189b1e0cdc91c\">immunity</span> improves and an exaggerated <span class=\"customMeta\" data-dictid=\"dc6add5cf91692777189b30a6bae38\">immune response</span> occurs against TB leading to IRIS.</li>\n\t<li>To prevent IRIS, ATT therapy is started first in patients diagnosed with <span class=\"customMeta\" data-dictid=\"fa9d83d3d41692777189a8b393dd60\">HIV</span> + TB, and 2 weeks later ART therapy is begun.</li>\n\t<li>IRIS can also occur in transplant recipients after <span class=\"customMeta\" data-dictid=\"498d3df3a416927771894f595a597a\">immunosuppression</span> withdrawal.</li>\n</ul>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": "https://image.prepladder.com/content/oYFwXA8GpbUjNVuWtEBv1750242561.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/6rqBnA3Trf3aIqG6yfS31750242662.mp3"
    },
    {
      "text": "A 55-year-old male patient who has undergone kidney transplantation is now presenting with signs of renal dysfunction. Which complement activation product is a known histological marker for the diagnosis of antibody-mediated rejection in transplant biopsies?",
      "choices": [
        {
          "id": 0,
          "text": "C3d"
        },
        {
          "id": 1,
          "text": "C5a"
        },
        {
          "id": 2,
          "text": "C3b"
        },
        {
          "id": 3,
          "text": "C4d"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct Answer: 4</strong>) C4d</p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<p> </p>\n\n<p>C4d is a <span class=\"customMeta\" data-dictid=\"cf14b794fb16927771847567191a08\">cleaved</span> fragment of the <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> protein C4 and serves as a distinctive indicator of endothelial damage, marking <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> activity. Its <span class=\"customMeta\" data-dictid=\"723fdec66b1692777186e92f0c6fdf\">detection</span> in <span class=\"customMeta\" data-dictid=\"ce12dc160c1692777195473ab2cc21\">peritubular</span> capillaries is <span class=\"customMeta\" data-dictid=\"8d0fca798b1692777191b6cd41880f\">linked</span> to the antibody-mediated <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> process in <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"1a6d065f851692777189ba5533d1ef\">humoral</span> rejection.</p>\n\n<p style=\"text-align: center;\"><img alt=\"\" data-author=\"Loh, Alwin.\" data-hash=\"\" data-license=\"CC BY NC\" data-source=\"https://www.researchgate.net/figure/Diffuse-positive-staining-for-C4d-in-peritubular-capillaries-This-patient-received-an_fig1_285637969\" data-tags=\"\" height=\"908\" src=\"https://image.prepladder.com/content/CRirM7HuRTL9eXPCUvXn1737002920.png\" width=\"1195\" /></p>\n\n<p>Image: <span class=\"customMeta\" data-dictid=\"05f7cf0b5f169277718982db56ba2a\">Immunoperoxidase</span> <span class=\"customMeta\" data-dictid=\"b29a1a16ab1692777199ede1c6e28b\">stain</span> shows <span class=\"customMeta\" data-dictid=\"17de2bdd881692777183cece8590b6\">C4d</span> deposition in <span class=\"customMeta\" data-dictid=\"ce12dc160c1692777195473ab2cc21\">peritubular</span> capillaries and a glomerulus.</p>\n\n<p> \n<p><strong>C3d (Option A)</strong>: <span class=\"customMeta\" data-dictid=\"ec65d8f4a51692777183cbb5e16e1e\">C3d</span> is a <span class=\"customMeta\" data-dictid=\"903370f259169277718385f6060dd7\">breakdown</span> product of the <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> component C3 and can indicate <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> activation, but it is not the most specific marker for antibody-mediated rejection.</p>\n</p>\n\n<p> </p>\n\n<p><strong>C5a (Option B)</strong>: <span class=\"customMeta\" data-dictid=\"0d70f956b016927771839d0cd35100\">C5a</span> is an <span class=\"customMeta\" data-dictid=\"2f962cb5221692777181c0637dc78a\">anaphylatoxin</span> produced during <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> that has potent <span class=\"customMeta\" data-dictid=\"9d21dd5d3116927771907405b181bc\">inflammatory</span> effects and can recruit neutrophils and macrophages. While it plays a role in inflammation, it is not typically used as a <span class=\"customMeta\" data-dictid=\"1e9c8202241692777189dbac6cc062\">histological</span> marker for antibody-mediated rejection.</p>\n\n<p> </p>\n\n<p><strong>C3b (Option C): </strong>C3b is another <span class=\"customMeta\" data-dictid=\"903370f259169277718385f6060dd7\">breakdown</span> product of C3 and acts as an <span class=\"customMeta\" data-dictid=\"1e48f7c1d01692777194e28f2253d2\">opsonin</span> that promotes <span class=\"customMeta\" data-dictid=\"aa86b61bdd1692777195ea42ef0356\">phagocytosis</span> and further <span class=\"customMeta\" data-dictid=\"f0ff39a3fa1692777184cf743ca1e7\">complement</span> activation. It is not explicitly used as a marker for antibody-mediated <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> in transplant patients.</p>\n\n<p> </p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/content/CRirM7HuRTL9eXPCUvXn1737002920.png"
      ],
      "explanation_audio_eng": "https://image.prepladder.com/content/4qSOX2yRQxI79LdZyq2X1750242724.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/HyLPTuxGK1qatIWj6lXB1750242791.mp3"
    },
    {
      "text": "A patient presented with oliguria for the last three days. She is a known case of diabetic nephropathy and underwent an allogeneic renal transplant four years ago. The physician suspects a possibility of graft rejection. Which of the following is not true regarding the suspected condition in this patient?",
      "choices": [
        {
          "id": 0,
          "text": "Predominantly antibody-mediated reaction"
        },
        {
          "id": 1,
          "text": "Manifests as interstitial fibrosis and narrowing of graft blood vessels"
        },
        {
          "id": 2,
          "text": "HPE shows duplication of the basement membrane"
        },
        {
          "id": 3,
          "text": "Its morphologic correlate in the lung is bronchiolitis obliterans"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct answer: A) Predominantly antibody-mediated reaction</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation:</strong></p>\n\n<ul>\n\t<li>The clinical scenario suggests chronic transplant rejection, which is predominantly mediated by T cells, not antibodies. T cells react against <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> alloantigens and <span class=\"customMeta\" data-dictid=\"7b8c92219216927771981950fdd0e8\">secrete</span> cytokines that stimulate fibroblasts and <span class=\"customMeta\" data-dictid=\"526ede3fee169277720184378acc5e\">vascular</span> smooth muscle cells in the graft.</li>\n\t<li>Chronic <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> is a <span class=\"customMeta\" data-dictid=\"26a46d0aaa169277720147f4f40f57\">type 4</span> > 2 <span class=\"customMeta\" data-dictid=\"2c7e1ce33316927771892ce1da8276\">hypersensitivity</span> reaction.</li>\n\t<li>The patient's symptoms appear four years post-transplant, which is consistent with chronic rejection. <span class=\"customMeta\" data-dictid=\"8b6287a6e2169277718447e54e52b5\">Chronic rejection</span> typically occurs months to years after transplantation.</li>\n\t<li>While antibodies can play a role in chronic rejection, the primary mechanism involves T cell-mediated <span class=\"customMeta\" data-dictid=\"e747a47db616927771908bff4b8931\">inflammation</span> and fibrosis. <strong>(Option A)</strong></li>\n\t<li>Histological: <span class=\"customMeta\" data-dictid=\"8b6287a6e2169277718447e54e52b5\">Chronic rejection</span> is characterised by <span class=\"customMeta\" data-dictid=\"f46ba26d111692777190def3b1d80a\">interstitial</span> fibrosis, <span class=\"customMeta\" data-dictid=\"98d387b7bd1692777201278b27be72\">tubular</span> atrophy, and <span class=\"customMeta\" data-dictid=\"526ede3fee169277720184378acc5e\">vascular</span> changes, which are more consistent with cell-mediated processes than antibody-mediated damage.</li>\n\t<li>Chronic <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> leads to gradual loss of <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> function over time, which aligns with the patient's presentation of <span class=\"customMeta\" data-dictid=\"a37e635d211692777194eb7748e0cf\">oliguria</span> after four years.</li>\n\t<li>Contrast with <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> rejection: <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">Acute</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> typically occurs earlier (within 6 months) post-transplant and has different <span class=\"customMeta\" data-dictid=\"1e9c8202241692777189dbac6cc062\">histological</span> features.</li>\n\t<li>Chronic <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> <span class=\"customMeta\" data-dictid=\"49e378f9f71692777197bc5e458569\">rejection</span> is the most common cause of <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> failure.</li>\n</ul>\n\n<p style=\"text-align:center\"><img alt=\"\" data-author=\"Haugk, Beate & El-Refaie, Ahmed & Burt, Alastair.\" data-hash=\"\" data-license=\"NA\" data-source=\"https://www.researchgate.net/figure/Arteriopathic-changes-in-chronic-rejection-with-foam-cells-within-the-intima-H-E_fig1_271580629\" data-tags=\"\" height=\"908\" src=\"https://image.prepladder.com/content/oi1b1jDV6iwaXvgLhdOH1737002779.png\" width=\"1201\" /></p>\n\n<p style=\"text-align: center;\"><strong>Graft <span class=\"customMeta\" data-dictid=\"9585714f62169277718293ae885f64\">arteriosclerosis</span> is caused by T-cell cytokines and <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> deposition in chronic <span class=\"customMeta\" data-dictid=\"a283380a9a1692777188549537a964\">graft</span> rejection.</strong></p>\n\n<p> </p>\n\n<p> </p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/content/oi1b1jDV6iwaXvgLhdOH1737002779.png"
      ],
      "explanation_audio_eng": "https://image.prepladder.com/content/3P7BYAgW0GaWK64z3oPL1750244937.mp3",
      "explanation_audio_hin": "https://image.prepladder.com/content/fVQZkBmU6rS2u8v6aaum1750245316.mp3"
    }
  ]
}